Alectinib and gastrointestinal perforation in ALK-rearranged non-small cell lung cancer: A case series
{{output}}
Background: Alectinib, a second-generation ALK inhibitor, is used in first-line and adjuvant treatment for ALK-rearranged NSCLC, and has proven to be both effective and well tolerated. Gastrointestinal (GI) perforation is an extr... ...
